VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $786,609 | -7.1% | 29,231 | +4.0% | 0.36% | -18.5% |
| Q2 2023 | $846,305 | +1559.4% | 28,107 | +1216.5% | 0.44% | +1309.7% |
| Q3 2022 | $51,000 | -23.9% | 2,135 | -12.9% | 0.03% | -16.2% |
| Q2 2022 | $67,000 | +97.1% | 2,452 | +179.0% | 0.04% | +146.7% |
| Q1 2022 | $34,000 | +21.4% | 879 | 0.0% | 0.02% | +25.0% |
| Q4 2021 | $28,000 | +7.7% | 879 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $26,000 | -13.3% | 879 | 0.0% | 0.02% | -11.8% |
| Q2 2021 | $30,000 | +7.1% | 879 | +0.3% | 0.02% | 0.0% |
| Q1 2021 | $28,000 | 0.0% | 876 | +11.0% | 0.02% | -22.7% |
| Q4 2020 | $28,000 | +47.4% | 789 | +53.5% | 0.02% | +22.2% |
| Q3 2020 | $19,000 | – | 514 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |